Award

Brachytherapy Delivery System for Treatment of Lung Cancer

Description: Project Narrative This development will afford the additional clinical benefit of brachytherapy to patients with compromised cardiopulmonary status, thereby improving their outcomes. The improved dose distribution resulting from more precise source positioning and fixation is expected to improve the currently identified clinical benefit of brachytherapy due to the limitations of the current technique. Because lung cancer is the leading cause of cancer deaths in the United States, any improvement in clinical outcome resulting from this program will translate into significant societal benefit.

Funder: National Cancer Institute

Funding type: research

Funder scheme: R44

Start date: 2007-08-01

End date: 2011-09-29

Investigator: JOHN J MUNRO

Institution: SOURCE PRODUCTION AND EQUIPMENT COMPANY

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

Funded outputs count: 2

Funder award ID: R44CA125999

OpenAlex ID: G7993071891

Dosimetric characterization of the GammaClip™169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection

2013 · Blake Currier, John J. Munro, et al. · Medical Physics · 7

PDF

A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer

2010 · Kara Lynne Leonard, Thomas A. DiPetrillo, et al. · Brachytherapy · 15